{"id":"https://openalex.org/W4361889421","doi":"https://doi.org/10.1158/1078-0432.22478579","title":"Supplementary Figure S2 from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes","display_name":"Supplementary Figure S2 from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361889421","doi":"https://doi.org/10.1158/1078-0432.22478579"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22478579","doi":"https://doi.org/10.1158/1078-0432.22478579","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22478579","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S2_from_Tarloxotinib_Is_a_Hypoxia-Activated_Pan-HER_Kinase_Inhibitor_Active_Against_a_Broad_Range_of_HER-Family_Oncogenes/22478579/1/files/39930080.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S2_from_Tarloxotinib_Is_a_Hypoxia-Activated_Pan-HER_Kinase_Inhibitor_Active_Against_a_Broad_Range_of_HER-Family_Oncogenes/22478579/1/files/39930080.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022348436","display_name":"Adriana Estrada\u2010Bernal","orcid":"https://orcid.org/0000-0002-0555-2766","observed_orcids":["https://orcid.org/0000-0002-0555-2766"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adriana Estrada-Bernal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100753119","display_name":"Anh Tuan Le","orcid":"https://orcid.org/0000-0003-4221-0914","observed_orcids":["https://orcid.org/0000-0003-4221-0914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anh T. Le","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4221-0914","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004389580","display_name":"Andrea E. Doak","orcid":"https://orcid.org/0000-0002-7325-6889","observed_orcids":["https://orcid.org/0000-0002-7325-6889"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea E. Doak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037183800","display_name":"Vijaya G. Tirunagaru","orcid":"https://orcid.org/0000-0002-6505-8858","observed_orcids":["https://orcid.org/0000-0002-6505-8858"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vijaya G. Tirunagaru","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051692752","display_name":"Shevan Silva","orcid":"https://orcid.org/0000-0002-9942-1897","observed_orcids":["https://orcid.org/0000-0002-9942-1897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shevan Silva","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9942-1897","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082738447","display_name":"Matthew R. Bull","orcid":"https://orcid.org/0000-0002-9388-0021","observed_orcids":["https://orcid.org/0000-0002-9388-0021"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew R. Bull","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030727604","display_name":"Jeff Bruce Smaill","orcid":"https://orcid.org/0000-0003-2954-6093","observed_orcids":["https://orcid.org/0000-0003-2954-6093"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeff B. Smaill","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2954-6093","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024840477","display_name":"Adam Vorn Patterson","orcid":"https://orcid.org/0000-0001-5138-1227","observed_orcids":["https://orcid.org/0000-0001-5138-1227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam V. Patterson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5138-1227","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100741251","display_name":"Chul Kim","orcid":"https://orcid.org/0000-0003-0191-8684","observed_orcids":["https://orcid.org/0000-0003-0191-8684"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chul Kim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0191-8684","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043871151","display_name":"Stephen V. Liu","orcid":"https://orcid.org/0000-0002-4852-3914","observed_orcids":["https://orcid.org/0000-0002-4852-3914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen V. Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4852-3914","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034705456","display_name":"Robert Charles Doebele","orcid":"https://orcid.org/0000-0001-6728-6857","observed_orcids":["https://orcid.org/0000-0001-6728-6857"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert C. Doebele","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6728-6857","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5917999744415283,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5917999744415283,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.3970000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypoxia-activated-prodrug","display_name":"hypoxia-activated prodrug","score":0.8999999761581421},{"id":"https://openalex.org/keywords/egfr-exon-20-insertion-mutation","display_name":"EGFR exon 20 insertion","score":0.8550000190734863},{"id":"https://openalex.org/keywords/patient-derived-cell-lines","display_name":"patient-derived cell lines","score":0.8669999837875366},{"id":"https://openalex.org/keywords/cell-line-characterization","display_name":"cell line characterization","score":0.625}],"concepts":[{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.5530934929847717},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4881752133369446},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.4507933259010315},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3283165693283081},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1936672329902649}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22478579","doi":"https://doi.org/10.1158/1078-0432.22478579","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22478579","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S2_from_Tarloxotinib_Is_a_Hypoxia-Activated_Pan-HER_Kinase_Inhibitor_Active_Against_a_Broad_Range_of_HER-Family_Oncogenes/22478579/1/files/39930080.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22478579","doi":"https://doi.org/10.1158/1078-0432.22478579","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22478579","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S2_from_Tarloxotinib_Is_a_Hypoxia-Activated_Pan-HER_Kinase_Inhibitor_Active_Against_a_Broad_Range_of_HER-Family_Oncogenes/22478579/1/files/39930080.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361889421.pdf","grobid_xml":"https://content.openalex.org/works/W4361889421.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3115703756","https://openalex.org/W4361958246","https://openalex.org/W2786975350","https://openalex.org/W2982154817","https://openalex.org/W3135184108","https://openalex.org/W2982083339","https://openalex.org/W4362610006","https://openalex.org/W2981807214","https://openalex.org/W3180915513","https://openalex.org/W4250465857"],"abstract_inverted_index":{"Patient":[0],"derived":[1],"EGFR":[2],"exon":[3],"20":[4],"insertion":[5],"mutation":[6],"cell":[7],"line":[8],"characterization.":[9]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}